When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
VTVT - vTv Therapeutics: What Can Investors Expect In The Future?
vTv Therapeutics Inc.
vTv Therapeutics Inc. (VTVT) is a pharmaceutical company with 7 drug candidates currently in different clinical stages. The programs are mainly focused on Alzheimer’s disease, diabetes, and inflammation. However, its most promising candidate, azeliragon, just failed Phase 3 trial for its intended co-primary endpoints. The company is now planning to conduct further clinical studies. Nevertheless, it is running out of cash and the expenses needed for additional trials would be a big problem for the company at the moment. It is unclear, how vTv will fund its operations in the future, and one big